ATE382101T1 - Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen - Google Patents
Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungenInfo
- Publication number
- ATE382101T1 ATE382101T1 AT05764390T AT05764390T ATE382101T1 AT E382101 T1 ATE382101 T1 AT E382101T1 AT 05764390 T AT05764390 T AT 05764390T AT 05764390 T AT05764390 T AT 05764390T AT E382101 T1 ATE382101 T1 AT E382101T1
- Authority
- AT
- Austria
- Prior art keywords
- autism
- gene
- diagnosis
- encoding
- disorder
- Prior art date
Links
- 206010003805 Autism Diseases 0.000 title abstract 4
- 208000020706 Autistic disease Diseases 0.000 title abstract 4
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 102000040945 Transcription factor Human genes 0.000 title 1
- 108091023040 Transcription factor Proteins 0.000 title 1
- 238000003745 diagnosis Methods 0.000 abstract 2
- 230000035772 mutation Effects 0.000 abstract 2
- 101150103310 pitx1 gene Proteins 0.000 abstract 2
- 108700028369 Alleles Proteins 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000006096 Attention Deficit Disorder with Hyperactivity Diseases 0.000 abstract 1
- 208000020925 Bipolar disease Diseases 0.000 abstract 1
- 208000030979 Language Development disease Diseases 0.000 abstract 1
- 208000036626 Mental retardation Diseases 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 208000012202 Pervasive developmental disease Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 208000029560 autism spectrum disease Diseases 0.000 abstract 1
- 210000000349 chromosome Anatomy 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 208000026278 immune system disease Diseases 0.000 abstract 1
- 208000030159 metabolic disease Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000020016 psychiatric disease Diseases 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58413004P | 2004-07-01 | 2004-07-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE382101T1 true ATE382101T1 (de) | 2008-01-15 |
Family
ID=35432082
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05764390T ATE382101T1 (de) | 2004-07-01 | 2005-06-30 | Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20070218068A1 (https=) |
| EP (1) | EP1761649B1 (https=) |
| JP (1) | JP4949240B2 (https=) |
| AT (1) | ATE382101T1 (https=) |
| AU (1) | AU2005258838B2 (https=) |
| CA (1) | CA2571365A1 (https=) |
| DE (1) | DE602005004026T2 (https=) |
| ES (1) | ES2299059T3 (https=) |
| IL (1) | IL179751A (https=) |
| WO (1) | WO2006003520A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110118135A1 (en) * | 2008-01-09 | 2011-05-19 | State Matthew W | Mutations in Contaction Associated Protein 2 (CNTNAP2) are Associated with Increased Risk for Ideopathic Autism |
| WO2009150221A1 (en) * | 2008-06-12 | 2009-12-17 | Integragen | A method for autism prediction |
| EP2963129A3 (en) * | 2008-11-12 | 2016-05-11 | University of Utah Research Foundation | Autism associated genetic markers |
| WO2011067296A1 (en) | 2009-12-01 | 2011-06-09 | Integragen | A combination of eight risk alleles associated with autism |
| KR101167942B1 (ko) | 2010-02-12 | 2012-07-23 | 차의과학대학교 산학협력단 | Ａｌｇ12 유전자로부터 유래된 단일염기다형을 포함하는 폴리뉴클레오티드, 이를 포함하는 마이크로어레이 및 진단키트, 및 이를 이용한 자폐 스펙트럼 장애 분석방법 |
| CA2797319A1 (en) | 2010-05-04 | 2011-11-10 | Integragen | A new combination of eight risk alleles associated with autism |
| EP2860265B1 (en) | 2011-02-24 | 2016-10-26 | The Chinese University of Hong Kong | Determining fetal DNA percentage for twins |
| CN111808943B (zh) * | 2020-06-18 | 2021-07-20 | 重庆浦洛通基因医学研究院有限公司 | 一种精神类个体化用药基因检测方法 |
-
2005
- 2005-06-30 AT AT05764390T patent/ATE382101T1/de active
- 2005-06-30 CA CA002571365A patent/CA2571365A1/en not_active Abandoned
- 2005-06-30 AU AU2005258838A patent/AU2005258838B2/en not_active Ceased
- 2005-06-30 DE DE602005004026T patent/DE602005004026T2/de not_active Expired - Lifetime
- 2005-06-30 ES ES05764390T patent/ES2299059T3/es not_active Expired - Lifetime
- 2005-06-30 JP JP2007519914A patent/JP4949240B2/ja not_active Expired - Fee Related
- 2005-06-30 US US11/570,543 patent/US20070218068A1/en not_active Abandoned
- 2005-06-30 EP EP05764390A patent/EP1761649B1/en not_active Expired - Lifetime
- 2005-06-30 WO PCT/IB2005/002319 patent/WO2006003520A2/en not_active Ceased
-
2006
- 2006-11-30 IL IL179751A patent/IL179751A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE602005004026T2 (de) | 2008-12-24 |
| EP1761649A2 (en) | 2007-03-14 |
| ES2299059T3 (es) | 2008-05-16 |
| EP1761649B1 (en) | 2007-12-26 |
| WO2006003520A2 (en) | 2006-01-12 |
| CA2571365A1 (en) | 2006-01-12 |
| AU2005258838B2 (en) | 2009-05-14 |
| IL179751A0 (en) | 2007-05-15 |
| US20070218068A1 (en) | 2007-09-20 |
| JP4949240B2 (ja) | 2012-06-06 |
| WO2006003520A3 (en) | 2006-03-02 |
| JP2008504837A (ja) | 2008-02-21 |
| DE602005004026D1 (de) | 2008-02-07 |
| IL179751A (en) | 2011-01-31 |
| AU2005258838A1 (en) | 2006-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jiang et al. | Transcriptomic and functional studies reveal undermined chemotactic and angiostimulatory properties of aged microglia during stroke recovery | |
| JO3076B1 (ar) | نظم العلاج المناعي المعتمد على حالة apoe | |
| MX338421B (es) | Anticuerpos fosfoespecificos que reconocen la proteina tau. | |
| WO2008151803A3 (en) | New polymorphisms in abcb1 associated with a lack of clinical response to medicaments | |
| ATE493405T1 (de) | Pyrimidinylamidverbindungen, die die durch vla-4 vermittelte leukozytenadhäsion inhibieren | |
| DK1656458T3 (da) | Human autisme-susceptibilitetsgen og anvendelser deraf | |
| ATE382101T1 (de) | Einen transkriptionsfaktor kodierendes humanes prädispositionsgen für autismus sowie dessen verwendungen | |
| MX2014000113A (es) | Compuestos para tratar neuropatias perifericas y otros desordenes neurodegenerativos. | |
| GB2473579A (en) | Stat3 and TYK2 as drug targets for neurodegenerative diseases | |
| IL185868A0 (en) | Human autism susceptibility gene encoding a transmembrane protein and uses thereof | |
| ATE424469T1 (de) | Für prkcb1 kodierendes humanes autismus- suszeptibilitätsgen und dessen verwendung | |
| WO2006087634A3 (en) | Uses of human autism susceptibility gene encoding a kinase | |
| WO2008070311A3 (en) | Gene expression profiling of parkinson's disease | |
| WO2006090288A3 (en) | Human autism susceptibility genes encoding a neurotransmitter transporter and uses thereof | |
| WO2001020025A3 (en) | Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications | |
| DE602006020754D1 (de) | Carbamatverbindungen, die die durch vla-4 vermittelte leukozytenadhäsion inhibieren | |
| WO2006003526A8 (en) | Human autism susceptibility gene encoding otoa and uses thereof | |
| ATE443160T1 (de) | Für einen spannungsgesteuerten kaliumkanal kodierendes humanes adipositas- suszeptibilitätssgen und dessen verwendung | |
| Gray et al. | 1.091 A LARGE RANDOMISED TRIAL ASSESSING QUALITY OF LIFE IN PATIENTS WITH EARLY PD: RESULTS FROM PD MED EARLY | |
| WO2003097683A3 (en) | Human obesity susceptibility gene and uses thereof | |
| Chena et al. | The role of ALDH2 and its substrates in central nervous system disorders | |
| AU3925701A (en) | Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications | |
| Pagonabarraga et al. | 1.090 HALLUCINATIONS IN DRUG-NAÍVE, NEWLY-DIAGNOSED PARKINSON'S DISEASE | |
| WO2005021787A3 (en) | Human obesity susceptibility gene and uses thereof | |
| Robb et al. | Introduction: Psychopharmacology. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1761649 Country of ref document: EP |